Fund moves

Boston Scientific (BSX): Impax Asset Management Group plc added to its stake +815K shares

Impax Asset Management Group plc added to its stake in Boston Scientific, per its Q3 2024 13F.

5.47M
Shares reported · +815K vs prior quarter
1.8%
Disclosed portfolio weight
$457M
Reported value
Holdings as of
Sep 30, 2024
Filed
Nov 6, 2024

What stands out in this filing

  • 4,654,771 shares in Q2 2024, 5,470,174 now (+17.5% in share count).
  • Reported at $457M, 1.80% of the portfolio value in this 13F filing.
  • 56 other tracked managers reported the same kind of change for Q3 2024.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 1, 2024InsiderOfficer sold ~$586K of BSX shares in the open market
  2. Oct 7, 2024Insider · 2 peopleInsiders: 3 sales (~$25.0M)
  3. Nov 1, 2024InsiderOfficer sold ~$589K of BSX shares in the open market
  4. Nov 5, 2024Insider · 1 personInsiders: 2 sales (~$13.8M)

What came next

  1. Nov 8, 2024InsiderOfficer sold ~$2.68M of BSX shares in the open market
  2. Nov 21, 2024InsiderDirector sold ~$447K of BSX shares in the open market
  3. Nov 25, 2024InsiderOfficer sold ~$1.25M of BSX shares in the open market
  4. Nov 27, 2024InsiderOfficer sold ~$121K of BSX shares in the open market
  5. Dec 2, 2024InsiderOfficer sold ~$634K of BSX shares in the open market
  6. Dec 3, 2024InsiderOfficer purchased ~$4.5K of BSX shares in the open market
  7. Dec 10, 2024InsiderOfficer sold ~$1.8K of BSX shares in the open market
  8. Dec 20, 2024FDARecall: AXIOS Stent and Delivery System 10mmx10mm UPN: M00553740
  9. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 10mmx10mm UPN: M00553540
  10. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 20mmx10mm UPN: M00553560
  11. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx10mm UPN: M00553550
  12. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx10mm UPN: M00553650
  13. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx15mm UPN: M00553670
  14. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 6mmx8mm UPN: M00553680
  15. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 10mmx10mm UPN: M00553640
  16. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 8mmx8mm UPN: M00553690
  17. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 8mmx8mm UPN: M00553530
  18. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx15mm UPN: M00553570
  19. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 6mmx8mm UPN: M00553520
  20. Dec 20, 2024FDARecall: AXIOS Stent and Delivery System 15mmx10mm UPN: M00553750
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

How this filing works

Explore the data

Common questions

What does this filing report about Boston Scientific (BSX) stock?

Impax Asset Management Group plc added to its stake in Boston Scientific, per its Q3 2024 13F. Now 5.47M shares, $457M reported value, 1.8% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Sep 30, 2024. Filed: Nov 6, 2024.

What stands out in this filing?

4,654,771 shares in Q2 2024, 5,470,174 now (+17.5% in share count). Reported at $457M, 1.80% of the portfolio value in this 13F filing. 56 other tracked managers reported the same kind of change for Q3 2024.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Boston Scientific recently?

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.

Does this mean BSX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data